Skip to content
10-Q

Quarterly Report

INMED PHARMACEUTICALS INC. INM

0001213900-26-052920

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · May 4, 2026 3.31M sh
Shares Diluted Q3 2026 · Mar 31, 2026 4.05M sh
Shares Diluted Q3 2026 · Mar 31, 2026 3.99M sh
Shares Diluted Q3 2026 · Mar 31, 2025 1.1M sh
Shares Diluted Q3 2026 · Mar 31, 2025 803.91K sh
Operating Cash Flow Q3 2026 · Mar 31, 2026 −$5.68M
Operating Cash Flow Q3 2026 · Mar 31, 2025 −$5.99M
Short Term Investments Q3 2026 · Mar 31, 2026 $41.63K
Short Term Investments Q3 2026 · Jun 30, 2025 $43.38K
Cash And Equivalents Q3 2026 · Mar 31, 2026 $5.16M
Cash And Equivalents Q3 2026 · Jun 30, 2025 $10.74M
Stockholders Equity Q3 2026 · Mar 31, 2026 $6.89M
Stockholders Equity Q3 2026 · Dec 31, 2025 $9.59M
Stockholders Equity Q3 2026 · Sep 30, 2025 $11.59M
Stockholders Equity Q3 2026 · Jun 30, 2025 $13.43M
Stockholders Equity Q3 2026 · Mar 31, 2025 $7.02M
Stockholders Equity Q3 2026 · Dec 31, 2024 $6.18M
Stockholders Equity Q3 2026 · Sep 30, 2024 $8.4M
Stockholders Equity Q3 2026 · Jun 30, 2024 $9.21M
Current Liabilities Q3 2026 · Mar 31, 2026 $2.21M
Current Liabilities Q3 2026 · Jun 30, 2025 $1.84M
Total Liabilities Q3 2026 · Mar 31, 2026 $2.24M
Total Liabilities Q3 2026 · Jun 30, 2025 $2.15M
Current Assets Q3 2026 · Mar 31, 2026 $6.89M
Current Assets Q3 2026 · Jun 30, 2025 $12.87M
Total Assets Q3 2026 · Mar 31, 2026 $9.13M
Total Assets Q3 2026 · Jun 30, 2025 $15.58M
Eps Diluted Q3 2026 · Mar 31, 2026 −$0.73
Eps Diluted Q3 2026 · Mar 31, 2026 −$1.69
Eps Diluted Q3 2026 · Mar 31, 2025 −$1.94
Eps Diluted Q3 2026 · Mar 31, 2025 −$7.93
Eps Basic Q3 2026 · Mar 31, 2026 −$0.73
Eps Basic Q3 2026 · Mar 31, 2026 −$1.69
Eps Basic Q3 2026 · Mar 31, 2025 −$1.94
Eps Basic Q3 2026 · Mar 31, 2025 −$7.93
Sga Expense Q3 2026 · Mar 31, 2026 $1.74M
Sga Expense Q3 2026 · Mar 31, 2026 $4.3M
Sga Expense restated Q3 2026 · Mar 31, 2025 $1.58M
Sga Expense restated Q3 2026 · Mar 31, 2025 $4.16M
Rd Expense Q3 2026 · Mar 31, 2026 $1.02M
Rd Expense Q3 2026 · Mar 31, 2026 $2.22M
Rd Expense restated Q3 2026 · Mar 31, 2025 $425.37K
Rd Expense restated Q3 2026 · Mar 31, 2025 $2.24M
Net Income Q3 2026 · Mar 31, 2026 −$2.97M
Net Income Q3 2026 · Mar 31, 2026 −$6.72M
Net Income Q3 2026 · Dec 31, 2025 −$2.03M
Net Income Q3 2026 · Sep 30, 2025 −$1.73M
Net Income Q3 2026 · Mar 31, 2025 −$2.12M
Net Income Q3 2026 · Mar 31, 2025 −$6.37M
Net Income Q3 2026 · Dec 31, 2024 −$2.58M
Net Income Q3 2026 · Sep 30, 2024 −$1.68M